Ulrik B. Nielsen - Net Worth and Insider Trading
Ulrik B. Nielsen Net Worth
The estimated net worth of Ulrik B. Nielsen is at least $544,539 dollars as of 2024-04-28. Ulrik B. Nielsen is the Director of Merrimack Pharmaceuticals Inc and owns about 36,968 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $544,539. Details can be seen in Ulrik B. Nielsen's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ulrik B. Nielsen has not made any transactions after 2022-01-24 and currently still holds the listed stock(s).
Transaction Summary of Ulrik B. Nielsen
Ulrik B. Nielsen Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ulrik B. Nielsen owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Ulrik B. Nielsen’s form 4 insider trades.
Insider Ownership Summary of Ulrik B. Nielsen
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2022-01-24 | director |
Ulrik B. Nielsen Latest Holdings Summary
Ulrik B. Nielsen currently owns a total of 1 stock. Ulrik B. Nielsen owns 36,968 shares of Merrimack Pharmaceuticals Inc (MACK) as of January 24, 2022, with a value of $544,539.
Latest Holdings of Ulrik B. Nielsen
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2022-01-24 | 36,968 | 14.73 | 544,539 |
Holding Weightings of Ulrik B. Nielsen
Ulrik B. Nielsen Form 4 Trading Tracker
According to the SEC Form 4 filings, Ulrik B. Nielsen has made a total of 1 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 14,287 shares on January 24, 2022, which cost Ulrik B. Nielsen around $60,577.
Insider Trading History of Ulrik B. Nielsen
- 1
Ulrik B. Nielsen Trading Performance
GuruFocus tracks the stock performance after each of Ulrik B. Nielsen's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ulrik B. Nielsen is 28.34%. GuruFocus also compares Ulrik B. Nielsen's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ulrik B. Nielsen within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ulrik B. Nielsen's insider trading performs compared to the benchmark.
Performance of Ulrik B. Nielsen
Average Return
160.32%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 46.26 | 28.34 | 16.14 | 160.32 | 73.4 | |
| Relative Return to S&P 500(%) | 49.01 | 31.48 | 26.31 | 169.24 | 68.33 |
Ulrik B. Nielsen Ownership Network
Ownership Network List of Ulrik B. Nielsen
Ownership Network Relation of Ulrik B. Nielsen
Ulrik B. Nielsen Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Ulrik B. Nielsen is the director of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Ulrik B. Nielsen made no insider transaction in Merrimack Pharmaceuticals Inc (MACK). Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 942,726 shares made by Eric Andersen , a net purchase of 100,000 shares made by Noah G. Levy , and a net purchase of 4,156 shares made by Ana Radeljevic .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 1,050,882 shares were bought by its insiders, resulting in a net purchase of 1,050,882 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Ulrik B. Nielsen Mailing Address
Above is the net worth, insider trading, and ownership report for Ulrik B. Nielsen. You might contact Ulrik B. Nielsen via mailing address: Merrimack Pharmaceuticals, Inc., One Kendall Square, Suite B7201, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
